https://www.europeanpharmaceuticalreview.com/developing-micro-qc-for-atmps/188475.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/outsourcing-regulatory-activities-in-pharma/188483.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/microbiome-innovation-have-we-forgotten-the-basics/190074.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-to-advance-haematology-cell-therapy/190535.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/financial-factors-to-support-and-challenge-pharma-in-2024/190548.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/driving-qbd-as-a-quality-standard-in-drug-development/190557.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-authorisation-is-first-endocrine-therapy-innovation-in-decades/190584.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-ingelheim-agrees-2bn-sirna-therapeutic-collaboration/190590.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/regulatory-revision-essential-for-bioprocess-iiot-adoption/190599.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-drug-delivery-method-shows-promise-in-alzheimers/190626.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/preventative-approach-could-reduce-immunotherapy-side-effects/190644.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/collaboration-to-develop-novel-ai-designed-oncology-therapy/190664.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/genai-in-pharma-where-are-we-today/190672.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/positive-data-from-schizophrenia-clinical-trials-revealed/190680.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/expanded-pluvicto-production-gets-fda-go-ahead/190721.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-biologic-for-myasthenia-gravis-granted-european-approval/190726.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/transforming-pharmaceutical-manufacturing-the-ai-revolution/190733.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-collaboration-could-transform-neonatal-therapy/190792.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizer-achieves-novel-eu-approval-for-prostate-cancer-treatment/190796.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vaccine-demonstrates-benefit-in-delaying-cancer-relapse/190817.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/video-unveiling-the-science-behind-ngs/190828.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/navigating-the-unique-cmc-challenges-of-oral-anaerobic-live-biotherapeutics/190834.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/schedio-sa/190848.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/tackling-the-complex-development-landscape-of-pain-medicines/190854.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-reducing-gas-consumption-by-20-during-the-micronization/190866.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sustainability-in-bet-from-your-endotoxin-experts/190872.article 2026-03-10T10:00:23.623Z https://www.europeanpharmaceuticalreview.com/accelerating-drug-development-for-simple-and-complex-drug-programmes/190877.article 2026-03-04T12:08:35.880Z https://www.europeanpharmaceuticalreview.com/news/first-european-ustekinumab-biosimilar-to-stelara-approved/190903.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/spectroscopy-milestone-signals-advance-in-protein-imaging/190913.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-plans-120m-european-manufacturing-expansion/190930.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-takeda-streamlines-analytical-handling/190932.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/achieving-optimal-advanced-process-control-in-bioproduction/190945.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-approves-safer-medicine-alternative-for-rare-disease/190950.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-plastic-alternative-support-environmentally-sustainable-drug-delivery/190992.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/bridging-the-healthcare-digital-divide-a-gradual-approach-to-adopting-epi/191007.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/roche-cancer-immunotherapy-receives-new-eu-approval/191027.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-heart-failure-drug-could-halt-disease-progression/191042.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-artificial-intelligence/191048.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/could-novel-antibiotic-successfully-treat-a-priority-1-pathogen/191094.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/market-outlook-to-2032-future-trends-across-the-seven-major-markets/191113.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/long-term-findings-from-car-nk-cell-therapy-trial-revealed/191125.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-imaflow-platinum-silicone-brewing-in-coffee-vending/191126.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/uk-atmp-sector-robust-research-finds/191145.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-innovative-breast-cancer-drug/193487.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/single-use-systems-to-drive-eandl-testing-market-growth/196367.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-what-are-some-hidden-risks-associated-with-isolators/196469.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/optimised-method-could-facilitate-analysis-of-complex-biologics/196499.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/will-new-therapeutic-agent-replace-antibodies-for-bacterial-detection/201488.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-bets-17b-on-potential-best-in-class-rare-disease-therapy/204118.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-of-a-kind-psoriasis-study-outcomes-revealed/204129.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-guidance-highlights-eandl-considerations-for-ophthalmic-drug-products/204248.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-evp-of-global-quality-to-retire/204262.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/key-vaccine-adjuvant-biosynthesised/204360.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/pharmaceutical-industry-2023-in-retrospect/204370.article 2026-04-02T08:44:33.873Z https://www.europeanpharmaceuticalreview.com/news/eosinophilic-esophagitis-medicine-approval-expanded/204405.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/medicines-for-europe-calls-for-simpler-spc-manufacturing-waiver/204582.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/revised-iso-guideline-highlights-toxicological-evaluation-of-extractables-and-leachables/204603.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/single-use-support/204657.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-january-2024/204675.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/immunotherapy-drug-achieves-trial-first-in-fifty-years/204707.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-filling-gaps-in-managing-large-volumes-of-biologics/204766.article 2026-03-12T16:08:03.680Z https://www.europeanpharmaceuticalreview.com/news/wuxi-biologics-achieves-large-scale-manufacturing-milestone/204815.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/taming-cardiovascular-risk-the-promise-of-ldl-cholesterol-lowering-therapeutics/204842.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-the-chilled-future-of-mrna-filling-and-freezing/204923.article 2026-03-12T16:07:33.767Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-injectable-bispecific-antibody-for-aggressive-blood-cancer/204940.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bcma-car-t-therapy-facilitates-potential-autoimmune-breakthrough/204989.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biosensing-technique-promising-for-whole-genome-detection/205053.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biogen-refocuses-its-alzheimers-strategy/205068.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/construction-of-major-radioligand-therapy-manufacturing-site-begins/205078.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/us-legislation-to-benefit-small-molecule-drug-innovation/205235.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-11b-acquisition-to-support-manufacturing-capacity/205268.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/suanfarma-realigns-brand-to-showcase-innovative-spirit/205313.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ema-annex-1-qanda-discusses-bioburden-considerations/205323.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/how-will-automation-shape-deviation-management-in-continuous-bioprocessing/207221.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-to-boost-cell-therapy-operations-with-300m-manufacturing-investment/207240.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rapid-microbiology-testing-market-to-value-nearly-13bn-by-2034/207736.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-unique-particle-sizes-via-spiral-jet-mills/207804.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/next-in-class-combination-treatment-shows-potential-in-cystic-fibrosis/207921.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/biologics-manufacturing-trends-in-a-modern-facility/208010.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/inhalable-dry-powder-drug-formulation-could-treat-respiratory-infections/208869.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biontech-agrees-collaboration-to-accelerate-autologous-car-t-therapies/208882.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/raman-and-machine-learning-show-promise-for-online-monitoring-of-bioreactors/209817.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vertex-secures-european-approval-for-crispr-cell-therapy/210092.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/usp-recommends-revisions-to-proposed-rmm-chapters/210318.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmaceutical-suspension-market-to-witness-accelerated-growth/210757.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-plans-43-billion-deal-to-advance-liver-portfolio/210780.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nelson-labs-facility-expansion-to-benefit-parenteral-and-ophthalmic-drug-product-manufacturers/211075.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-chemotherapy-treatment-could-benefit-multiple-cancer-types/211167.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/overcoming-challenges-of-continuous-antibody-manufacture/211717.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-immunotherapy-approved-for-melanoma/212486.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/patient-centricity-for-tailor-made-healthcare/212538.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/who-initiative-to-enhance-biomanufacturing-in-lmics/212805.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/single-use-technology-propelling-upstream-bioprocessing-market-expansion/213400.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-manufacturing-output-expected-to-improve-despite-challenges/213870.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/egfr-inhibitor-could-provide-major-advance-in-lung-cancer/213898.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/lonza-qc-testing-solutions/214067.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/driving-the-uks-innovation-engine-for-novel-amr-therapeutics/214085.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-first-medicine-for-severe-alopecia-areata/214186.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovation-to-drive-advanced-drug-delivery-market/214232.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-1-2024/214420.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/analysis-reveals-superior-efficacy-of-long-acting-injectable-hiv-treatment/214470.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-announces-its-new-ceo/214506.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sgs-joins-forces-with-agilex-biolabs/214906.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/forward-thinking-cdmo-tackles-the-dynamic-challenge-of-n-nitrosamines-control-with-high-performance-analytical-instrumentation/214953.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/under-the-microscope-time-to-consider-perfusion/214983.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-february-2024/215020.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-reveals-major-data-from-liver-disease-trial/215033.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/making-atmps-a-reality-for-rare-disease-patients/215177.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/news/amgen-opens-its-most-advanced-manufacturing-facility-to-date/215200.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/2024-pharmaceutical-industry-trends-discover-the-latest-pharma-quality-and-manufacturing-trends/215203.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/delivery-systems-for-biologics/215232.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/mhra-chief-executive-to-step-down/215257.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/rare-disease-spotlight-first-eu-approved-treatment-for-friedreichs-ataxia/215551.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/implications-of-ai-regulation-for-data-integrity/215608.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-high-fidelity-process-control-with-brukers-fourier-pat/215832.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-first-licenced-treatment-for-al-amyloidosis/215944.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/joint-investment-to-accelerate-uk-sustainable-biomanufacturing/216586.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-antibody-drug-formulation-wins-novel-mhra-approval/216792.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/validation-of-analytical-procedures-ich-q2r2/217349.article 2026-04-02T08:45:27.817Z https://www.europeanpharmaceuticalreview.com/analytica-2024-in-overview/217374.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-data-revealed-for-novartis-sma-gene-therapy/217424.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ebook-a-practical-guide-to-single-use-filtration-in-biopharma/217511.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-beigene-head-of-europe-global-clinical-operations-appointed/217520.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/developing-new-treatment-regimens-for-hiv/217548.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/medical-device-manufacturers-must-remain-vigilant-to-ensure-data-integrity-of-premarket-submissions/217601.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-automated-set-up-of-the-pyrogene-rfc-assay/217791.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/process-analytics-for-the-new-era-of-continuous-rna-manufacturing/217799.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fractionation-purification-and-downstream-processing-the-path-to-commercialisation/217866.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sandoz-granted-novel-biosimilars-approval/217911.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-radiopharmaceutical-laboratory-opens-in-germany/217938.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-future-of-targeted-alpha-therapy-development-and-manufacture/217962.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/uk-manufacturing-and-randd-to-benefit-from-new-360m-investment/218211.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/employing-maldi-tof-ms-for-microbial-identification-in-sterile-drug-manufacturing/218271.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/the-role-of-gamp-5-data-integrity-and-qbd-in-pharmaceutical-quality-assurance/218579.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/semaglutide-could-provide-novel-dual-benefit-in-diabetes-and-kidney-disease/218682.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/preventing-fungal-contamination-in-pharmaceuticals/218914.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/live-biotherapeutic-products-bridging-innovations-and-challenges-in-manufacturing/218926.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/manufacturer-retracts-acquisition-deal-due-to-data-integrity-issues/218949.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/inlet-air-conveyor-optimisation-in-a-continuous-tablet-coater/219588.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/data-integrity-considerations-in-pharma-and-life-sciences/219686.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-warning-letters-highlight-data-integrity-issues/219951.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/jandj-reveal-long-term-data-for-novel-oral-peptide/219984.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rapid-pseudomonas-aeruginosa-detection-method-developed/220005.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-environmental-monitoring/220030.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/developing-a-new-treatment-paradigm-for-igan/220123.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/innovative-method-could-offer-cost-effective-sterilisation-approach/220151.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/manufacturing-facility-expansion-to-advance-next-gen-vaccine/220180.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-collaboration-could-advance-first-in-class-schizophrenia-treatments/220197.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approval-could-shape-liver-disease-treatment-landscape/220343.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-complete-automation-system-for-endotoxin-testing/220365.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/analytical-technique-may-advance-medical-cannabis-quality-control/220373.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mycoplasma-testing-market-expected-to-value-nearly-2-million-by-2031/220386.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/bruker/220635.article 2026-03-05T12:58:50.407Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-manufacturing-with-brukers-fourier-pat/220640.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/parkinsons-infusion-treatment-demonstrates-advantage-over-oral-delivery/220646.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-agrees-novel-1-billion-endocrine-acquisition/220667.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/solution-brief-environmental-monitoring-software/220680.article 2026-03-10T09:47:16.797Z https://www.europeanpharmaceuticalreview.com/news/mould-study-highlights-safer-far-uvc-light-cleaning-alternative/220711.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-acquisition-to-address-inflammation-driven-diseases/220800.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biologics-driving-continuous-bioprocessing-market-expansion/220837.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lonza-to-acquire-major-biologics-manufacturing-facility/221095.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-innovative-gene-therapy-for-mld/221137.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/germany-largest-revenue-contributor-in-europes-lims-market/221141.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/control-strategy-could-facilitate-faster-bioburden-detection/221271.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-advanced-therapies-to-get-179-million-boost/221329.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/researchers-propose-novel-test-for-pyrogen-detection/221425.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/combination-treatment-could-minimise-cancer-relapse-risk/221467.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-march-2024/221477.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-to-buy-cardior-pharmaceuticals/221701.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/positive-chmp-recommendation-for-antibiotic-combination/221714.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/unlocking-innovative-hydrogel-treatments/221720.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/astellas-breaks-ground-on-new-facility/221728.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-redefining-clinical-trial-decision-making-leveraging-nlp-for-extracting-insights-from-unstructured-data/221745.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/clinical-trials-for-rare-diseases/221849.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/next-gen-moderna-covid-19-vaccine-shows-promise/221889.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/trends-in-technology-transfer/221913.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/drug-safety-driving-pyrogen-testing-market-expansion/222019.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/is-the-pharmaceutical-sector-realising-its-potential-for-sustainable-manufacturing/222023.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-biologic-approved-for-rare-lung-disease/222091.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/strong-growth-for-swedens-pharmaceutical-exports/222113.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ebook-twin-screw-extrusion-for-pharmaceutical-applications/222337.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/quality-risk-management-in-radiopharmaceutical-production/222447.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmaceutical-environmental-monitoring-market-to-value-381b-by-2030/222484.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/moving-towards-continuous-batch-rna-production/222569.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/coherent-raman-scattering-microscopy-a-powerful-tool-for-pharmaceutics/222651.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/novel-lai-antipsychotic-approved-in-eu/223469.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/one-time-gene-therapy-could-improve-wet-amd/223639.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lonza-appoints-new-chief-executive/225364.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/endotoxin-testing-the-international-regulatory-landscape/225373.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ep-monographs-allow-rfc-for-water-testing/225394.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/adc-oncology-acquisition-to-address-solid-tumours/225396.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinar-how-pfizer-utilises-enzyme-indicator-technology-for-bio-decontamination-validation/225439.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/biopharmaceuticals-contributing-to-manufacturing-outsourcing-trend/225489.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/championing-uk-atmp-clinical-trials/225505.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-partnership-to-aid-supply-of-ga-68-based-radiopharmaceuticals/225520.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-anaemia-therapy-granted-expanded-approval/225586.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mrna-therapy-could-provide-intracellular-protein-replacement-for-rare-disease/225668.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/antibody-immunotherapy-treatment-shows-benefit-in-serious-endometrial-cancer/225673.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-microbiome-innovation/226039.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/the-role-of-outsourcing-in-antibody-drug-manufacture/226054.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-personalised-immunotherapy-approved-for-multiple-myeloma/226096.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/achieving-fair-bacterial-identification/226136.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cdmo-acquires-meppel-facility-from-astellas/226154.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/aacr-btk-degrader-could-treat-cns-b-cell-malignancies/226166.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/unique-testing-regimen-could-prevent-nuclease-contamination/226263.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/patent-expiration-to-drive-biosimilars-market-expansion-to-2032/226316.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/low-dose-injectable-could-aid-prenatal-depression/226329.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/monitoring-pharmaceuticals-in-the-environment/226352.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-partnership-to-advance-european-oligonucleotide-manufacturing/226365.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/efpia-reaction-to-european-parliament-plenary-vote/226386.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/crispr-technologies-fuelling-haematological-innovations/226429.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-medicine-could-address-short-stature-in-children/226440.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/seasonal-variation-of-microbial-contamination-in-pharmaceutical-cleanrooms/226582.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fujifilm-plans-12-billion-investment-in-major-us-manufacturing-facility/226605.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/long-term-data-indicates-significant-potential-of-agvhd-microbiome-treatment/226620.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/teva-enters-into-oncology-biosimilar-licensing-agreement/226663.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-and-japanese-pharmacopoeias-partner-to-harmonise-pharmacopoeial-standards/226672.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-releases-new-data-for-innovative-rare-kidney-disease-treatment/226681.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/technology-advancement-driving-growth-of-rapid-sterility-testing-market/226690.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/encouraging-data-for-roche-multiple-sclerosis-injection/226732.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/application-of-ngs-to-enhance-the-molecular-monitoring-of-cml-patients/226734.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/using-mass-spectrometry-to-improve-quality-and-safety-of-levothyroxine/226763.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/analysis-of-corticosteroid-formulations-in-metered-dose-inhalers/226829.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/antibiotic-demonstrates-non-inferiority-to-a-leading-gonorrhoea-treatment/226847.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-competitiveness-of-european-life-sciences/226887.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/genentech-oncology-treatment-granted-first-of-a-kind-approval/226911.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/microbial-burden-assessment-of-solid-pharmaceutical-products/226928.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/widening-adoption-of-animal-free-reagents-for-endotoxin-testing/227037.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/utilising-rapid-uhplc-for-tablet-qc-analysis/227055.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/supporting-female-leaders-to-advance-cell-and-gene-therapies/227064.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-commission-approves-novel-antibiotic/227071.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/safeguarding-purity-under-pressure-detecting-nitrosamine-contamination/227079.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/aav-gene-therapy-demonstrates-positive-activity-in-duchenne-muscular-dystrophy/227103.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bms-inks-car-t-cell-therapy-manufacturing-deal-with-cellares/227120.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/study-monitors-particles-and-falling-bacteria-in-biosafety-cabinets/227133.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-2-2024/227149.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bioprocessing-/-bioproduction-in-depth-focus-2024/227160.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-testing-2024/227164.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-novartis-precision-brain-cancer-treatment/227263.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/under-the-microscope-using-recombinant-reagents-for-bet/227284.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/microbe-carrying-particle-recovery-efficacy-with-manual-surface-sampling/227291.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-isokinetic-microbial-air-sampling-on-mas-100-instruments/227300.article 2026-03-06T16:50:57.130Z https://www.europeanpharmaceuticalreview.com/news/generics-propelling-pharmaceutical-parenteral-packaging-market/227333.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/research-calls-for-greater-investment-in-alzheimers-clinical-trials/227456.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/stress-impact-on-protein-particle-formation-for-monoclonal-antibody-formulation/227466.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-jak-inhibitor-shows-potential-in-novel-atopic-dermatitis-head-to-head-trial/227574.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/from-viral-vectors-to-nucleic-acids-biopharmas-evolving-manufacturing-landscape/227612.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-commission-authorises-one-of-first-ustekinumab-biosimilars-in-europe/227615.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/benefits-of-3d-printing-for-personalised-medicine-formulation/227640.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cgt-catapult-appoints-new-non-executive-directors/227651.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rapid-method-for-whole-genome-fungal-id/227744.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-haemophilia-b-gene-therapy-approved/227752.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/who-proposes-recommendations-for-preventing-nitrosamine-contamination/227856.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/accelerating-spectroscopic-analysis-for-data-acquisition/227878.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-april-2024/227900.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-medicine-manufacturing-through-digitalisation/227933.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/insights-into-astrazenecas-mandara-phase-iii-data/227938.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/booklet-air-filtration-upgrades-without-compromise/227948.article 2026-03-06T16:39:10.537Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-high-temperature-filters-for-sterilization-and-depyrogenation-processes/227968.article 2026-03-06T16:39:10.537Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-molecular-contamination-control-odours-gases-and-toxics/227976.article 2026-03-06T16:39:10.537Z https://www.europeanpharmaceuticalreview.com/news/abbvie-breaks-ground-on-new-randd-centre/227979.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/what-is-the-future-of-biologic-medicines/227992.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/long-acting-antibody-demonstrates-promising-efficacy-in-infant-rsv/228001.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-publishes-strategy-on-ai-regulation/228038.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-pat-tool-could-improve-pharmaceutical-qc/228051.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-new-haemolytic-anaemia-treatment/228079.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/dissolution-of-capsule-with-cross-linking/228094.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pioneering-the-next-wave-of-lbp-based-therapeutics/228105.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/combination-treatment-could-provide-new-standard-of-care-for-aggressive-lymphoma/228110.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/alternative-methods-for-mycobacterial-testing-in-biological-products/228357.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/landmark-genetic-blindness-crispr-trial-outcomes-released/228366.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/injectable-drug-delivery-market-to-value-11394b-by-2029/228415.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-approves-new-medicine-formulations-for-hiv-prevention/228431.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/intravesical-drug-delivery-system-exhibits-bladder-cancer-benefit/228461.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/potential-best-in-class-antibody-shows-remarkable-efficacy-in-atopic-dermatitis/228503.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/key-vaccine-adjuvant-biosynthesised-in-yeast/228519.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/challenges-and-opportunities-in-the-cgt-supply-chain/228530.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/us-agencies-collaborate-to-address-regulation-for-biotechnology-products/228579.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/oxford/az-covid-19-vaccine-to-be-discontinued/228587.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-preservation-method-could-improve-storage-of-biologics/228597.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/improving-accuracy-of-spectroscopy-for-protein-analysis/228713.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mrna-cancer-vaccine-granted-world-first-approval/228744.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/addressing-drug-delivery-challenges-of-emerging-drug-modalities/228755.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-cell-and-gene-therapy/228833.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/why-patient-centricity-is-essential-to-accelerate-rare-disease-clinical-research/228848.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/advancing-pharmaceutical-technology-trends-and-innovations-at-achema-2024/228875.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/impact-of-eu-sustainability-directive-on-supply-chains/228889.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-adds-to-biomanufacturing-investment-in-france/228893.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/takeda-agrees-to-develop-active-immunotherapy-for-alzheimers/228964.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cell-therapy-could-help-curb-progression-of-heart-failure/228973.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancements-and-knowledge-gaps-in-ich-q2r2/228989.article 2026-03-31T21:27:19.797Z https://www.europeanpharmaceuticalreview.com/news/ensuring-sterility-of-a-novel-anti-vegf-bispecific-antibody/229035.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-evp-teva-global-operations-appointed/229070.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-pledges-45m-to-support-global-amr-prevention/229089.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-amgen-t-cell-engager-for-small-cell-lung-cancer/229124.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ema-recommends-suspension-of-hydroxyprogesterone-caproate-medicines/229130.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/effective-data-quality-governance-challenging-five-common-myths/229141.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-announces-15b-adc-manufacturing-facility/229176.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-clinical-trial-regulation-may-support-haemophilia-treatment-access/229196.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-biologic-could-offer-ulcerative-colitis-symptomatic-remission/229232.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/msd-collaboration-to-drive-development-of-solid-tumour-combination-therapy/229243.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-authorities-recognised-for-leading-medicine-regulatory-oversight/229281.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ich-q14-latest-guideline-on-analytical-procedure-development/229300.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/progressing-personalised-cell-therapies-in-oncology/229305.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-commission-grants-first-of-a-kind-biosimilar-approval/229320.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-releases-new-data-for-innovative-oral-asthma-treatment/229338.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/development-of-novel-water-soluble-inks-for-3d-printed-polypills/229376.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/sfc-ms-advancements-and-applications-in-pharmaceutical-quality-control/229404.article 2026-03-31T21:25:35.850Z https://www.europeanpharmaceuticalreview.com/news/innovative-analytical-method-for-quality-control-of-nanomedicines/229411.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-phase-iii-data-for-hidradenitis-suppurativa-biologic-released/229427.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/delivering-long-acting-oral-treatments/229433.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pioneering-aav-gene-therapy-for-krabbe-disease/229442.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/major-manufacturing-investment-to-support-api-production-for-tirzepatide/229480.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/improving-stem-cell-transplantation-success-in-high-risk-blood-cancers/229485.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ampoules-packaging-market-forecast-to-2033/229490.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/harnessing-small-molecules-to-treat-chronic-inflammatory-diseases/229550.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/lignin-based-drug-delivery-system-may-improve-chemotherapeutics/229558.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/two-novel-biosimilars-approved-in-eu-and-us/229586.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lbp-immunotherapy-could-benefit-oncology-patients/229608.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ophthalmology-acquisition-to-advance-tri-specific-antibody/229659.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-nanocage-promises-sustainable-cancer-drug-delivery/229684.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/oligonucleotide-als-therapy-approved-in-eu/229724.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-franz-ziels-utilisation-of-enzyme-indicators-using-fractional-kill-time-method/229731.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sustainable-rp-hplc-method-for-simultaneous-determination-of-hypertension-drugs/229742.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-immunotherapy-could-boost-lung-cancer-survival/229796.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/technology-innovation-aiding-process-spectroscopy-market-growth/229804.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/the-ima-group-at-achema-2024--all-in-one-solutions-for-the-pharmaceutical-sector/229829.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-selects-new-evp-of-global-quality/229849.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/fresh-or-frozen-navigating-the-cryopreservation-dilemma-for-cgt/229851.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/biologic-demonstrates-durable-tumour-regression-in-rectal-cancer/229882.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovating-small-molecule-injectables-market-forecast-to-2033/229922.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-targeted-treatments-for-multiple-myeloma/229958.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/wuxi-facility-boosts-bioprocessing-capacity-with-new-bioreactors/229968.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/combination-therapy-may-hold-potential-for-severe-viral-hepatitis/229986.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinar-overcoming-contamination-risks-during-biologicals-production-mycoplasma-and-virus-testing/230015.article 2026-03-31T21:26:23.240Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-telomerase-inhibitor-approved-for-blood-cancer/230020.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/regulation-and-legislation-in-the-era-of-automation-and-digitalisation/230040.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/glp-1-treatment-displays-best-in-class-potential-for-mash/230065.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/prodrugs-seeking-perfection-in-an-imperfect-world/230136.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-validating-recombinant-cascade-reagents-in-3-simple-steps/230145.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-data-driven-water-system-maintenance/230146.article 2026-03-13T11:30:02.153Z https://www.europeanpharmaceuticalreview.com/news/innovative-radioligand-manufacturing-facility-inaugurated/230193.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/developing-the-eus-first-intestinal-microbiota-based-biologic/230201.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/five-year-data-from-genentech-sma-study-released/230210.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-polymer-based-drug-delivery-system-developed-for-tuberculosis/230253.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/efpia-sets-out-targets-for-pharma-environmental-sustainability/230261.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abpi-embraces-proposals-for-pharmas-growth-ahead-of-uk-elections/230302.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/analysis-of-chiral-compounds-using-supercritical-fluid-chromatography/230314.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/modifier-gene-therapy-clinical-development-and-manufacturing-considerations/230326.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/haemophilia-drug-could-reduce-treated-bleeding-episodes/230338.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-to-advance-tl1a-antibody-for-ibd/230366.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/jandj-commits-five-year-investment-in-italian-medicine-manufacturing/230386.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-immunotherapy-combination-approved-for-endometrial-cancer/230485.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/non-chemotherapy-lymphoma-treatment-may-provide-durable-remission/230529.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/big-potential-for-small-molecule-drugs-in-cancer-treatment/230545.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/semi-automation-of-manual-interventions-in-high-speed-filling-lines/230551.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/combining-biofermentation-and-chemical-synthesis-to-manufacture-complex-molecules-in-pharmaceutical-applications/230588.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/qa/qc-microbiology-in-depth-focus-2024/230593.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-3-2024/230600.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/press-release-overcoming-contamination-risks-during-biologicals-production-mycoplasma-and-virus-testing/230628.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-small-molecule-demonstrates-strong-capability-for-hiv-prevention/230634.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/guide-to-data-integrity-2024/230643.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/continuous-manufacturing-an-evolving-technology-for-drug-substance-manufacturing/230647.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/optimising-ips-cell-based-platelet-manufacturing-scale-up/230736.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-multiple-sclerosis-treatment-option-granted-in-eu/230766.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/one-hek-of-a-viral-vector-to-develop/230772.article 2026-03-13T11:29:32.343Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-automated-nucleic-acid-amplification-assay-for-mycoplasma-detection-in-cell-and-gene-therapy-products/230813.article 2026-03-13T11:28:44.757Z https://www.europeanpharmaceuticalreview.com/news/new-us-fill-finish-facility-receives-41-billion-investment/230824.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-highly-efficient-method-development-using-lc-ms-for-automated-peak-tracking/230827.article 2026-03-12T14:14:21.817Z https://www.europeanpharmaceuticalreview.com/whitepapers/advertorial-next-generation-microbial-testing-of-pharmaceuticals/230840.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/drug-approval-roundup-may/june-2024/230877.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-draft-guidance-promotes-diversity-in-clinical-trials/230882.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-small-molecule-shows-promise-in-obesity/230948.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-june-2024/231026.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/digital-simulations-could-advance-nanoparticle-drug-delivery/231063.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/botanical-drugs-what-is-the-best-way-forward-for-regulatory-and-market-approval/231091.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cleanroom-microbiology-single-temperature-incubation-for-em/231105.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/endotoxin-standards-reflection-and-recommendation/231116.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/optimising-reverse-phase-chromatography-for-molnupiravir-production/231121.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/accidental-media-switch-leads-to-car-t-therapy-discovery/231141.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharma-responds-to-2024-uk-general-election/231154.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-agrees-32b-ibd-acquisition/231186.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chromatography-analysis-for-nitrosamine-quantitation-in-pharmaceutical-manufacturing-water/231217.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-formulation/231234.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/boehringer-establishes-new-biomass-production-in-germany/231247.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/using-rack-systems-to-reduce-thermal-interactions-between-vials-during-freezing/231260.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/abbvie-appoints-new-chief-scientific-officer/231272.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/advanced-techniques-fuelling-demand-for-liquid-chromatography-reagents/231329.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/improving-aseptic-connections-throughout-the-manufacturing-process/231332.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/pharmas-attitudes-on-ai-revealed/231422.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-chromatography-method-shows-sustainability-potential/231447.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/uncovering-the-potential-of-adcs-to-target-tumours/231459.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/a-holistic-approach-to-safeguard-data-integrity-in-biopharma-manufacturing/231479.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-pharmacopoeia-makes-milestone-pyrogen-testing-commitment/231496.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-needs-rna-workforce-fit-for-the-future/231523.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/securing-europes-competitiveness-in-life-sciences/231529.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/generic-hiv-raltegravir-medicines-approved/231638.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/synthesis-and-route-design-to-tackle-api-complexity/231645.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/utilising-naturally-occurring-endotoxins-in-recovery-studies/231734.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/beigene-enhances-biologic-capability-with-new-us-facility/231781.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ipsen-agrees-new-oncology-licensing-deal/231821.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-route-to-enhanced-gene-therapies/231833.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/pfizer-receives-eu-haemophilia-b-gene-therapy-approval/231854.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-meeting-highlights-july-2024/231942.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eco-hplc-based-method-shows-promise-for-z-alkene-synthesis/231997.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-usp-water-conductivity-regulations/232025.article 2026-03-12T14:13:09.860Z https://www.europeanpharmaceuticalreview.com/news/from-biologics-to-small-molecules-the-shift-in-biopharmas-revenue-growth/232040.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/achieving-vlp-continuous-production-with-digital-twins/232067.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/alzheimers-drug-development-roundup-july-2024/232081.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-innovative-engineered-cell-therapy/232117.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/science-of-scale-for-spray-dried-intermediates/232205.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/sanofi-plant-to-help-secure-eu-insulin-supply/232216.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/downstream-process-shows-potential-for-oncolytic-virus-purification/232227.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/genentech-sangamo-deal-to-advance-neurodegenerative-treatments/232265.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/west-pharmaceutical-services-inc/232294.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/personalised-mrna-cancer-therapy-shown-to-boost-immune-response/232296.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/regulating-therapies-for-rare-diseases-recent-approvals/232324.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/hdfn-drug-trial-shows-capability-for-alloimmune-diseases/232364.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/msd-set-to-acquire-novel-antibody-for-b-cell-malignancies/232435.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sustainable-qc-method-for-antimicrobial-quantification/232447.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-therapy-approved-for-chronic-skin-disease/232454.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-vaccine-demonstrates-sustained-malaria-immunisation-in-pregnancy/232493.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/targeted-therapies-for-chronic-lymphocytic-leukaemia-in-an-evolving-treatment-landscape/232499.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/genmab-appoints-new-evp-and-chief-technology-officer/232518.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-cell-proliferation-in-bioproduction-with-non-invasive-technology/232537.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-of-a-kind-trial-holds-promise-for-obesity-and-pre-diabetes-treatment/232557.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-mass-spec-method-may-improve-oligonucleotide-therapeutic-analysis/232569.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/semi-automatic-method-could-provide-superior-bacterial-characterisation-analysis/232574.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/harnessing-the-glp-1r-medicine-wave/232595.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-successfully-navigating-complex-and-evolving-regulatory-environment-for-combination-products/232607.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/are-we-set-for-the-revised-eu-gmp-annex-1/232612.article 2026-03-31T21:21:33.733Z https://www.europeanpharmaceuticalreview.com/news/alzheimers-drug-milestone-bittersweet-for-certain-patients/232617.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-commission-licenses-first-treatment-for-acanthamoeba-keratitis/232657.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-investment-to-increase-biologic-capacity-in-sweden/232693.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-collaboration-to-innovate-subcutaneous-drug-delivery/232735.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-pharma-government-partnership-to-enhance-uk-clinical-trials/232759.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/mpox-update-august-2024/232778.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sustainable-pfas-free-synthesis-for-pharmaceutical-compounds/232807.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-hypertension-polypill-study-achieves-significant-outcomes/232834.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/improving-upstream-fermentation-with-end-to-end-automation/232864.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-who-guidance-to-support-manufacturers-to-reduce-amr-risk/232868.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-nox-inhibitors-for-treating-fibrotic-diseases-and-cancer/232948.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-combination-therapy-authorised-for-endometriosis/232956.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gene-therapy-trial-facilitates-major-vision-improvement/233011.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-cut-through-complexity-in-drug-development-ebook/233342.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/driving-economic-growth-in-uk-with-commercial-clinical-trials/233387.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-ultra-long-acting-biologic-shows-phase-iii-potential/233396.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/patient-insights-into-the-decentralisation-of-clinical-trials/233555.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/news/innovative-medicine-production-site-inaugurated-in-france/233574.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-18-billion-investment-to-bolster-irish-manufacturing/233616.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/enzyme-replacement-therapy-improving-outcomes-in-rare-disease/233622.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sepsis-addressing-unmet-needs-for-a-global-priority/233665.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-from-vial-to-prefilled-syringe/233891.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-collaboration-to-boost-access-to-innovative-microbiome-therapies/233905.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-biologics/233921.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-4-2024/233926.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/microbial-contamination-detection-with-rapid-spectroscopy/233963.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmalab-congress-2024-whats-new-for-the-third-year-in-dusseldorf/neuss/233993.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/who-guidance-aims-to-strengthen-clinical-trial-ecosystem/234004.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/quality-from-the-start-designing-a-scalable-aav-production-platform/234022.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-ready-are-you-preparing-for-the-impact-of-eu-gmp-annex-1-on-primary-packaging/234030.article 2026-03-06T13:09:38.303Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-single-temperature-analysis-for-environmental-monitoring-samples/234045.article 2026-03-13T11:25:55.600Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-therapy-approved-for-schizophrenia/234077.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/radiopharmaceutical-therapy-delivers-promising-meningioma-survival-rates/234471.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/a-data-driven-approach-to-container-closure-integrity/234519.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/optimising-wet-granulation-manufacturing-with-advanced-technologies/234533.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/environmental-monitoring-in-depth-focus-2024/234542.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/genentech-gains-rights-to-next-generation-cdk-inhibitors/234590.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/future-of-oral-small-molecule-drugs-addressing-potential-in-multiple-sclerosis/234618.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-manufacturing-facility-to-strengthen-gene-therapy-supply/234639.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhancing-intestinal-drug-delivery-with-quality-by-design/234691.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-real-world-study-reveals-encouraging-efficacy-for-cell-therapy/234745.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/improving-packaging-integrity-of-pharmaceutical-borosilicate-glass-vials/234761.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/cphi-milan-2024-everything-you-need-to-know/234776.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-appoints-chief-ai-officer/234790.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-environmental-monitoring-systems-for-cgt-manufacturing/234844.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ema-publishes-eu-strategy-to-2028/234854.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vaccines-essential-for-addressing-amr-says-who/234895.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/haemophilia-treatment-with-new-delivery-method-approved/234966.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/digitalisation-propelling-automated-microbiology-market-growth-to-2033/234973.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/aav-gene-therapy-manufacturing-gets-14m-boost/235000.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinars/when-innovative-formulations-cloud-sterility-testing/235016.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/innovating-allergy-drug-delivery-with-a-needle-free-alternative/235050.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sanofi-collaboration-to-advance-innovative-radioligand-therapies/235062.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/immunotherapy-treatment-enhances-lymphoma-survival-landmark-study-shows/235092.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/drug-combination-shows-promise-for-mitigating-microbial-biofilms/235126.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/world-first-medicine-manufacturing-regulatory-framework-to-be-implemented/235132.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-secures-mhra-authorisation-for-alzheimers-treatment/235165.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/optimising-drug-release-of-personalised-3d-printed-tablets/235186.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/developing-donanemab-balancing-cost-versus-benefit/235198.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/delivering-market-success-for-concept-to-patient/235213.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/trial-highlights-potential-next-gen-biologic-for-lung-cancer/235242.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/acg-2024-jandj-data-reveals-new-crohns-treatment-option/235265.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-agrees-14-billion-alzheimers-acquisition/235282.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-nanoemulsion-based-delivery-of-antimycobacterial-drug/235297.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-optimise-organisational-culture-and-quality-maturity/235349.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/htba-healthtech-bioactives/235372.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/standout-breast-cancer-trial-outcomes-for-roche-small-molecule-therapy/235375.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/life-sciences-response-to-2024-autumn-budget/235382.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sustainability-continues-to-steer-pharmaceutical-packaging-market/235419.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/final-chapter-text-published-for-early-adoption/235443.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/encouraging-data-revealed-for-schizophrenia-long-acting-injectables/235467.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-risk-based-approach-to-development-injectable-combination-product/235519.article 2026-03-13T11:25:10.890Z https://www.europeanpharmaceuticalreview.com/news/first-of-a-kind-eu-approval-granted-for-eosinophilic-esophagitis-medicine/235542.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/single-use-bioreactor-market-to-witness-favourable-expansion-to-2030/235603.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-static-culturing-method-developed/235696.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/major-immunotherapy-trial-sees-survival-benefit-in-solid-tumours/235976.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-35b-astrazeneca-investment-to-accelerate-us-randd-and-manufacturing/236075.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-what-to-expect-from-a-regulatory-inspection-an-nsf-expert-guide/236095.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/gilead-data-lends-insight-into-transforming-hiv-prevention-landscape/236359.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biontech-oncology-acquisition-to-advance-bispecific-antibodies/236460.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-5-2024/236494.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-outsourcing-2024/236506.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-the-need-for-rapid-methods-in-the-compounding-pharmaceutical-industry/236517.article 2026-03-24T17:53:35.103Z https://www.europeanpharmaceuticalreview.com/the-future-of-media-hydration-balanced-media-in-automated-single-use-platforms/236523.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/understanding-endotoxin-cartridge-testing-frequently-asked-questions/236533.article 2026-03-06T12:38:44.093Z https://www.europeanpharmaceuticalreview.com/curated-and-customised-outsourcing/236539.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mas-100-libra-the-future-of-continuous-cleanroom-monitoring/236560.article 2026-03-10T09:52:35.220Z https://www.europeanpharmaceuticalreview.com/environmental-monitoring-in-depth-focus-2024/236570.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/modernising-drug-delivery-through-gel-based-technology/236648.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/beigene-proposes-new-name-reaffirming-oncology-mission/236653.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-investment-to-enhance-antibody-bioproduction-in-france/237061.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-and-ratio-to-progress-next-gen-radiotherapeutic/237147.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/selecting-fill/finish-manufacturing-technologies/237298.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/innovative-method-could-address-a-major-limitation-in-fluorescence-microscopy/237585.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/easing-the-mental-health-burden-with-psychedelic-therapies-whats-next-for-the-regulatory-and-clinical-landscape/237595.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/amgen-and-pfizer-appoint-new-science-executives/237695.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-sustainability/237741.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/innovating-lnp-design-to-improve-mrna-therapeutics/237899.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-eu-ai-act-will-regulation-drive-life-science-innovation-away-from-europe/238250.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ai-and-automation-to-drive-substantial-progress-in-pharmaceutical-analytical-testing/238259.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/glp-1-receptor-agonists-aid-broader-outcomes-in-kidney-disease-major-analysis-finds/238267.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/study-proposes-system-to-produce-endotoxin-free-recombinant-proteins/238411.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/regulatory-authority-inspection-comparison/238418.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sustainable-analytical-approach-devised-for-complex-drug-formulation/238531.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-mass-spectrometry-chapter-could-revolutionise-biopharma-quality-assurance/239023.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-to-advance-novel-huntingtons-disease-therapy/239031.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/preserving-antibiotic-efficacy-with-an-advanced-coating-process-to-prevent-amoxicillin-and-clavulanic-acid-tablet-degradation/239222.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/understanding-and-applying-updated-fda-guidance/239230.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/restoring-regulatory-excellence-central-to-uk-life-science-competitiveness/239309.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/investing-in-the-future-of-pharmaceutical-microbiology-qc/239369.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-collaboration-to-accelerate-biotech-manufacturing/239387.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/early-promise-for-novel-breast-cancer-immunotherapy/239499.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/16-million-to-fund-uk-switzerland-life-sciences-research/239768.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/nsfs-quality-management-maturity-qmm-assessment-model/239847.article 2026-03-10T10:02:28.060Z https://www.europeanpharmaceuticalreview.com/news/ash-2024-car-t-cell-therapy-demonstrates-durable-benefit-in-lymphoma/239868.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmapack-europe-2025-eco-barrier-packaging-to-launch/239971.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/targeting-ovarian-cancer-with-a-novel-antibody-therapeutic/240018.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/legislative-milestone-for-uk-clinical-trials/240039.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-biologic-prefilled-syringe-approved-in-eu/240117.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-investing-in-rare-disease-with-major-new-manufacturing-site/240371.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-recommends-novel-long-acting-hiv-treatment/240420.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/adopting-ai-for-randd-in-2025-what-needs-to-be-addressed/240463.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/cell-and-gene-therapy-containment/240533.article 2026-03-13T11:21:25.817Z https://www.europeanpharmaceuticalreview.com/news/antibody-drug-has-promise-as-next-frontier-in-inflammatory-bowel-disease/240536.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/early-allogeneic-cell-therapy-trial-results-offer-hope-for-sight-condition/240632.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-licenses-amyloid-beta-antibody-programme/240639.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanoparticle-drug-delivery-innovation-could-enhance-drug-development/240661.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/ich-q6r1-test-criteria-and-specifications/240788.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-automation-and-digital-technologies-will-unlock-the-full-potential-of-advanced-therapies/240796.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/next-generation-rapid-mrna-vaccine-cqa-analytics/190633.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/pittcon-conference-and-exposition/191038.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/applying-iso/tr-14644-21-airborne-particle-sampling-techniques/191060.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/interphex/191141.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/analytica/204348.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/mastering-pharma-40-validation-challenges-with-technology/204947.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/achema-2024/205229.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/are-outdated-microbial-identification-methods-risking-your-product-safety-and-operational-efficiency/207771.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/process-analytical-technology-applications-and-opportunities-for-pharma/210697.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/enhancing-biopharma-workflows-with-the-power-of-uv/vis-spectroscopy/217841.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/the-trend-towards-outsourced-buffer-manufacturing-in-biopharmaceuticals/218884.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/aaps-summer-scientific-forum-2024/220101.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/comprehensive-evaluation-of-growth-direct-rapid-sterility-for-microorganism-detection/221294.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/testing-of-rapid-microbiological-methods-rmms-demonstrating-equivalence-to-existing-methods-in-alignment-with-usp-/227265.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/register-for-the-2024-aaps-pharmsci-360/228599.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/pharmaceutical-continuous-manufacturing-whats-next-for-industry/228725.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/managing-the-complexities-of-ndsri-method-development-the-n-nitroso-propranolol-case-story/228918.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/enhancing-oral-drug-delivery-exploring-multiparticulate-systems/230180.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/defining-the-right-digital-strategy-for-oncology-what-do-you-want-to-measure/230471.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/simplifying-complex-dosage-forms-with-advanced-encapsulation/231381.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/unmasking-the-unknown-how-mass-spectrometry-delivers-accurate-identifications/231386.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/simplify-your-move-from-a-vial-to-a-prefilled-syringe/231939.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/an-alternative-medium-to-support-sterility-testing-using-the-growth-direct-rapid-sterility-system/232871.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/monocyte-activation-test-mat-insight-into-examining-regulations-and-markets-prospects/232981.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/turning-quality-management-into-quality-leadership/234489.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/the-path-to-optimisation-in-pharmaceutical-microbiology/235269.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/navigating-pharmaceutical-environmental-monitoring-in-a-changing-industry/239742.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/trends-for-life-sciences-quality-leaders-in-2025-mastering-what-matters/240382.article 2026-05-11T11:15:50.760Z